- €1.10bn
- €919.58m
- €665.38m
- 99
- 36
- 90
- 90
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 490 | 510 | 524 | 580 | 665 |
Cost of Revenue | |||||
Gross Profit | 348 | 367 | 374 | 409 | 454 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 444 | 456 | 473 | 518 | 592 |
Operating Profit | 46 | 53.7 | 51.9 | 61.6 | 72.9 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 47.6 | 53.8 | 53.6 | 61.8 | 72.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | 29.6 | 35.2 | 35 | 42.9 | 51.8 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 26 | 30.8 | 30.9 | 37.7 | 44.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 26 | 30.8 | 30.9 | 37.7 | 44.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.07 | 1.14 | 1.27 | 1.56 | 1.8 |
Dividends per Share |